RAM
MRVI icon

Readystate Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Readystate Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121,912
Closed -$294K – 572
2025
Q2 		$294K Sell
121,912
-50,081
-29% -$105K 0.01% 529
2025
Q1 		$380K Hold
171,993
– – 0.01% 502
2024
Q4 		$937K Buy
171,993
+33,571
+24% +$216K 0.03% 399
2024
Q3 		$1.15M Buy
+138,422
New +$1.2M 0.02% 390

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Readystate Asset Management's MRVI Position: Q3 2025 in Review

Readystate Asset Management sold out of Maravai LifeSciences (MRVI) in Q3 2025, closing a stake of 121,912 shares — an estimated $294K sold.

Readystate Asset Management first reported a position in MRVI in Q3 2024 and held it in 4 quarters. The position peaked at $1.15M in Q3 2024. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • Readystate Asset Management reported no remaining Maravai LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Readystate Asset Management sold 121,912 Maravai LifeSciences shares in Q3 2025, an estimated $294K.
  • Readystate Asset Management first reported a position in Maravai LifeSciences in Q3 2024 and held it in 4 quarters.
  • Readystate Asset Management's Maravai LifeSciences position peaked at $1.15M in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Readystate Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.